Canada Pension Plan Investment Board Purchases 15,100 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Canada Pension Plan Investment Board lifted its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 59.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 40,400 shares of the company's stock after purchasing an additional 15,100 shares during the quarter. Canada Pension Plan Investment Board's holdings in Option Care Health were worth $937,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Marshall Wace LLP raised its stake in shares of Option Care Health by 33.7% during the fourth quarter. Marshall Wace LLP now owns 1,097,714 shares of the company's stock valued at $25,467,000 after acquiring an additional 276,765 shares during the last quarter. Gamco Investors INC. ET AL grew its position in shares of Option Care Health by 18.9% in the 4th quarter. Gamco Investors INC. ET AL now owns 108,957 shares of the company's stock valued at $2,528,000 after buying an additional 17,334 shares during the last quarter. Gabelli Funds LLC increased its stake in shares of Option Care Health by 7.3% in the fourth quarter. Gabelli Funds LLC now owns 563,100 shares of the company's stock valued at $13,064,000 after buying an additional 38,458 shares during the period. Jump Financial LLC bought a new position in shares of Option Care Health during the fourth quarter worth about $1,790,000. Finally, Walleye Trading LLC boosted its holdings in Option Care Health by 159.7% in the fourth quarter. Walleye Trading LLC now owns 25,969 shares of the company's stock valued at $602,000 after acquiring an additional 15,969 shares during the last quarter. Institutional investors own 98.05% of the company's stock.

Insider Activity

In related news, insider Michael Bavaro sold 30,996 shares of the firm's stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the completion of the sale, the insider now owns 44,974 shares in the company, valued at approximately $1,495,835.24. This trade represents a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 0.64% of the company's stock.

Option Care Health Stock Up 5.3 %

Shares of NASDAQ:OPCH traded up $1.62 during mid-day trading on Wednesday, hitting $32.31. 4,194,293 shares of the company traded hands, compared to its average volume of 1,809,966. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The stock has a 50-day moving average price of $33.34 and a two-hundred day moving average price of $28.82. Option Care Health, Inc. has a 12-month low of $21.39 and a 12-month high of $35.53. The stock has a market cap of $5.31 billion, a P/E ratio of 27.15, a P/E/G ratio of 2.30 and a beta of 1.07.

Option Care Health (NASDAQ:OPCH - Get Free Report) last released its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.04. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. The business had revenue of $1.33 billion for the quarter, compared to analysts' expectations of $1.26 billion. During the same period in the previous year, the company earned $0.26 earnings per share. The firm's revenue for the quarter was up 16.3% compared to the same quarter last year. On average, equities research analysts forecast that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

Analyst Ratings Changes

OPCH has been the topic of a number of analyst reports. JPMorgan Chase & Co. upped their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a research note on Thursday, March 6th. Jefferies Financial Group raised Option Care Health from a "hold" rating to a "buy" rating and boosted their price objective for the company from $26.00 to $35.00 in a research note on Thursday, January 23rd. JMP Securities reiterated a "market outperform" rating and issued a $36.00 target price on shares of Option Care Health in a report on Tuesday, April 22nd. Bank of America upgraded Option Care Health from a "neutral" rating to a "buy" rating and increased their price target for the stock from $26.00 to $33.00 in a report on Monday, January 13th. Finally, UBS Group raised shares of Option Care Health from a "neutral" rating to a "buy" rating and increased their target price for the stock from $38.00 to $40.00 in a research note on Wednesday. One research analyst has rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $35.50.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.